SNPHY(SNPHY)
SNPHY
No analyst ratings available
No analyst price targets available for SNPHY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $308.41B | $327.39B |
| Low | $300.50B | $318.99B |
| High | $315.63B | $335.06B |
| EBITDA Avg | $68.73B | $79.95B |
| Low | $67.16B | $78.02B |
| High | $70.15B | $81.72B |
| EBIT Avg | $49.41B | $60.52B |
| Low | $47.84B | $58.58B |
| High | $50.83B | $62.28B |
| Net Income Avg | $39.47B | $48.82B |
| Low | $38.16B | $47.19B |
| High | $40.67B | $50.31B |
| EPS Avg | $120.20 | $148.67 |
| Low | $116.19 | $143.71 |
| High | $123.86 | $153.19 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $70.97B | $77.63B |
| Low | $69.23B | $75.27B |
| High | $72.01B | $79.13B |
| EBITDA Avg | $20.45B | — |
| Low | $19.97B | — |
| High | $20.74B | — |
| EBIT Avg | $15.69B | — |
| Low | $15.21B | — |
| High | $15.98B | — |
| Net Income Avg | $12.76B | — |
| Low | $12.35B | — |
| High | $13.00B | — |
| EPS Avg | $39.54 | — |
| Low | $38.28 | — |
| High | $40.29 | — |
| Analysts (Rev / EPS) | 2 / 1 | 3 / — |